English  |  正體中文  |  简体中文  |  0  
???header.visitor??? :  52807029    ???header.onlineuser??? :  570
???header.sponsordeclaration???
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
???ui.leftmenu.abouttair???

???ui.leftmenu.bartitle???

???index.news???

???ui.leftmenu.copyrighttitle???

???ui.leftmenu.link???

"hsu c"???jsp.browse.items-by-author.description???

???jsp.browse.items-by-author.back???
???jsp.browse.items-by-author.order1??? ???jsp.browse.items-by-author.order2???

Showing items 266-275 of 881  (89 Page(s) Totally)
<< < 22 23 24 25 26 27 28 29 30 31 > >>
View [10|25|50] records per page

Institution Date Title Author
臺大學術典藏 2021-08-10T03:53:07Z Inferior survival of advanced pancreatic cancer patients who received gemcitabine-based chemotherapy but did not participate in clinical trials SHIH-HUNG YANG; Kuo Y.-H.; Tien Y.-W.; Hsu C.; Hsu C.-H.; Kuo S.-H.; Cheng A.-L.
臺大學術典藏 2021-08-10T03:53:06Z Dynamics of circulating endothelial cells and endothelial progenitor cells in breast cancer patients receiving cytotoxic chemotherapy Kuo Y.-H.; Lin C.-H.; Shau W.-Y.; Chen T.-J.; SHIH-HUNG YANG; Huang S.-M.; Hsu C.; Lu Y.-S.; Cheng A.-L.
臺大學術典藏 2021-08-10T03:53:04Z Perspectives on the combination of radiotherapy and targeted therapy with DNA repair inhibitors in the treatment of pancreatic cancer SHIH-HUNG YANG; Kuo T.-C.; Wu H.; Guo J.-C.; Hsu C.; Hsu C.-H.; Tien Y.-W.; Yeh K.-H.; Cheng A.-L.; Kuo S.-H.
臺大學術典藏 2021-08-10T03:53:01Z A multicenter, phase I/II trial of biweekly S-1, leucovorin, oxaliplatin and gemcitabine in metastatic pancreatic adenocarcinoma�VTCOG T1211 study Chiang N.-J.; Tsai K.K.; Hsiao C.-F.; SHIH-HUNG YANG; Hsiao H.-H.; Shen W.-C.; Hsu C.; Lin Y.-L.; Chen J.-S.; Shan Y.-S.; Chen L.-T.
臺大學術典藏 2021-08-10T03:53:01Z Low-dose nab-paclitaxel-based combination chemotherapy in heavily pretreated pancreatic cancer patients SHIH-HUNG YANG; Guo J.-C.; Hsu C.; Kuo S.-H.; Tien Y.-W.; Cheng A.-L.; Yeh K.-H.
臺大學術典藏 2021-08-10T03:53:00Z Multicentre, phase II study of gemcitabine and S-1 in patients with advanced biliary tract cancer: TG1308 study Chiang N.-J.; Chen M.-H.; SHIH-HUNG YANG; Hsu C.; Yen C.-J.; Tsou H.-H.; Su Y.-Y.; Chen J.-S.; Shan Y.-S.; Chen L.-T.
臺大學術典藏 2021-08-05T02:37:30Z Study on the transient response to the point-to-point motion controls on a dual-axes air-bearing planar stage Kuo F.-C;Hsu C;Hsieh M.-R;Yen J.-Y;Chen L.-C;Chung T.-T;Wang F.-C.; Kuo F.-C; Hsu C; Hsieh M.-R; Yen J.-Y; Chen L.-C; Chung T.-T; Wang F.-C.; LIANG-CHIA CHEN
臺大學術典藏 2021-08-03T07:10:54Z Potential of circulating immune cells as biomarkers of nivolumab treatment efficacy for advanced hepatocellular carcinoma Hung Y.-P.; YU-YUN SHAO; Lee J.-M.; Hsu C.; Hsu C.-H.; Yang M.-H.; Chao Y.
臺大學術典藏 2021-08-03T07:10:53Z Management consensus guideline for hepatocellular carcinoma: 2020 update on surveillance, diagnosis, and systemic treatment by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan YU-YUN SHAO; Wang S.-Y.; Lin S.-M.; Chen K.-Y.; Tseng J.-H.; Ho M.-C.; Lee R.-C.; Liang P.-C.; Liao L.-Y.; Huang K.-W.; Hu J.-T.; Liang J.-D.; Kee K.-M.; Lin C.-L.; Wang C.-K.; Lu S.-N.; Wang J.-H.; Lee W.-C.; Chen C.-H.; Liu C.-J.; Huang Y.-H.; Wang C.-C.; Wang T.-E.; Chuang P.-H.; Dai C.-Y.; Hsu C.; Chen S.-C.; Hsieh C.-H.; Diagnosis Group, Systemic Therapy Group
臺大學術典藏 2021-08-03T07:10:52Z The unique characteristic in peripheral immune cells in patients with advanced hepatocellular carcinoma Hung Y.-P.; YU-YUN SHAO; Hsu C.; Hsu C.-H.; Lee J.-M.; Yang M.-H.; Chao Y.

Showing items 266-275 of 881  (89 Page(s) Totally)
<< < 22 23 24 25 26 27 28 29 30 31 > >>
View [10|25|50] records per page